AngioDynamics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -337.9% | – | -465.0% | – | -632.1% | – | -184.6% | – | -166.7% | – | – | |
| – | 0.0% | +12.5% | -9.4% | -0.5% | +1.1% | -7.9% | -7.7% | +3.2% | -3.4% | -5.1% | +1.4% | – | |
| – | -54.7% | +39.2% | -27.4% | +69.0% | -21.1% | -5.1% | -31.6% | +172.4% | -35.3% | -7.2% | +45.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +134.8% | -48.3% | -265.5% | – | -652.8% | – | -197.3% | – | -385.1% | – | – | |
| – | -30.0% | +596.2% | -85.3% | +92.9% | -27.0% | +125.6% | -56.8% | -5.9% | -42.3% | +140.5% | -59.3% | – | |
| – | -101.8% | – | -107.9% | +3.0% | -18.5% | +62.6% | -17.7% | -40.9% | +4.5% | -7.0% | -15.7% | – | |
| – | – | -100.0% | – | -256.8% | +102.5% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -200.0% | – | – | – | – | – | |
| – | -99.4% | – | -820.5% | -89.8% | +120.6% | – | -180.7% | – | -164.3% | – | -117.4% | – | |
| – | -74.5% | +430.4% | -113.6% | – | – | – | – | -253.9% | – | -233.1% | – | – | |
| – | – | -447.7% | – | -536.2% | – | -992.4% | – | -192.3% | – | -197.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.